摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(5Z,7E)-(1S,2S,3R,20S)-2-Methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol

中文名称
——
中文别名
——
英文名称
(5Z,7E)-(1S,2S,3R,20S)-2-Methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
英文别名
2β-methyl-20-epi-1β,3α,25-trihydroxyvitamin D3;(5E,7E)-(1S,2S,3R,20S)-2-methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol;2alpha-methyl-20-epi-1alpha,25-dihydroxyvitamin D3/2alpha-methyl-20-epi-1alpha,25-dihydroxycholecalciferol;(1R,2S,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2S)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-2-methyl-4-methylidenecyclohexane-1,3-diol
(5Z,7E)-(1S,2S,3R,20S)-2-Methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol化学式
CAS
——
化学式
C28H46O3
mdl
——
分子量
430.671
InChiKey
PSWKLSOBPNHZSY-ZBCLFYJUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.5
  • 重原子数:
    31
  • 可旋转键数:
    6
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.79
  • 拓扑面积:
    60.7
  • 氢给体数:
    3
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    (20S)-25-hydroxy Grundmann's ketone 在 tris(dibenzylideneacetone)dipalladium (0) 、 camphor-10-sulfonic acid 、 sodium hexamethyldisilazane三乙胺三苯基膦 作用下, 以 四氢呋喃甲醇氯仿甲苯 为溶剂, 生成 (5Z,7E)-(1S,2S,3R,20S)-2-Methyl-9,10-seco-5,7,10(19)-cholestatriene-1,3,25-triol
    参考文献:
    名称:
    Synthesis and biological activity of 2-methyl-20-epi analogues of 1α,25-dihydroxyvitamin D3
    摘要:
    Synthesis and biological evaluation of all eight possible A-ring diastereomers of 2-methyl-20-epi-1,25-dihydroxyvitamin D-3 are described. Among the analogues synthesized, 2 alpha-methyl-20-epi-1 alpha,25-dihydroxyvitamin D-3 exhibited exceptionally high potency. The double modification of 2-methyl substitution and 20-epimerization yielded analogues with unique activity profiles. (C) 1998 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(98)00363-1
点击查看最新优质反应信息

文献信息

  • Systematic studies on synthesis, structural elucidation, and biological evaluation of A-ring diastereomers of 2-methyl-1α,25-dihydroxyvitamin D3 and 20-epi-2-methyl-1α,25-dihydroxyvitamin D3
    作者:Hiroaki Takayama、Katsuhiro Konno、Toshie Fujishima、Shojiro Maki、Zhaopeng Liu、Daishiro Miura、Manabu Chokki、Seiichi Ishizuka、Connie Smith、Hector F. DeLuca、Kimie Nakagawa、Mayuko Kurobe、Toshio Okano
    DOI:10.1016/s0039-128x(00)00141-0
    日期:2001.3
    diastereomers of 2-methyl-1alpha,25-dihydroxyvitamin D(3) (2) and 20-epi-2-methyl-1alpha,25-dihydroxyvitamin D(3) (3) were synthesized by palladium-catalyzed coupling reaction of A-ring 'enyne' synthons with CD-ring portions. The A-ring synthons were rationally synthesized via a novel and practical route, starting with methyl (R)-(+)- and (S)-(-)-3-hydroxy-2-methyl-propionate, in good yields. X-ray
    通过催化合成了2-甲基-1α,25-二羟基维生素D(3)(2)和20-表-2-甲基-1α,25-二羟基维生素D(3)(3)的所有可能的A环非对映异构体。 A环“烯炔”合成子与CD环部分的偶联反应。A环合成子是通过新颖而实用的途径合理合成的,从(R)-(+)-和(S)-(-)-3-羟基-2-甲基丙酸甲酯开始,收率很高。X射线晶体学分析的2alpha-甲基-1alpha,25-二羟基维生素D(3)(2b)和构象分析的2alpha-甲基-(2b)和2beta-甲基-1alpha,25-二羟基维生素D(A环) 3)进行(2f),并对结果进行说明。如此合成的所有A环非对映异构体(2和3)均在体外和体内进行了生物学评估。生物学效力高度依赖于A环取代基的立体化学。特别是2b的维生素D受体[VDR]结合活性比天然激素高4倍,而其20受体(3b)则表现出异常高的活性,VDR结合的效力高12倍,动员7倍与
  • Synthesis, Biological Evaluation, and Conformational Analysis of A-Ring Diastereomers of 2-Methyl-1,25-dihydroxyvitamin D<sub>3</sub> and Their 20-Epimers:  Unique Activity Profiles Depending on the Stereochemistry of the A-Ring and at C-20
    作者:Katsuhiro Konno、Toshie Fujishima、Shojiro Maki、Zhaopeng Liu、Daishiro Miura、Manabu Chokki、Seiichi Ishizuka、Kentaro Yamaguchi、Yukiko Kan、Masaaki Kurihara、Naoki Miyata、Connie Smith、Hector F. DeLuca、Hiroaki Takayama
    DOI:10.1021/jm000261j
    日期:2000.11.1
    All eight; possible A-ring diastereomers of 2-methyl-1,25-dihydroxyvitamin D-3 (2) and 2-methyl-20-epi-1,25-dihydroxyvitamin D-3 (3) were convergently synthesized. The A-ring enyne synthons 19 were synthesized starting with methyl(S)-(+)- or (R)-(-)-3-hydroxy-2-methylpropionate (8). This was converted to the alcohol 14 as a 1:1 epimeric mixture in several steps. After having been separated by column chromatography, each isomer led to the requisite A-ring enyne synthons 19 again as 1:1 mixtures at C-1. Coupling of the resulting A-ring enynes 20a-h with the CD-ring portions 5a,b in the presence of a Pd catalyst afforded the 2-methyl analogues 2a-h and 3a-h in good yield. In this way, all possible A-ring diastereomers were synthesized. The synthesized analogues were biologically evaluated both in vitro and in vivo. The potency was highly dependent on the stereochemistry of each isomer. In particular, the alpha alpha beta -isomer 2g exhibited 4-fold higher potency than 1 alpha ,25-dihydroxyvitamin D-3 (1) both in bovine thymus VDR binding and in elevation of rat serum calcium concentration and was twice as potent, as the parent compound in HL-60 cell differentiation. Furthermore, its 20-epimer, that is, 20epi-alpha alpha beta 3g, exhibited exceptionally high activities: 12-fold higher in VDR binding affinity, 7-fold higher in calcium mobilization, and 590-fold higher in HL-60 cell differentiation, as compared to 1 alpha ,25-dihydroxyvitamin D3 (1). Accordingly, the double modification of 2-methyl substitution and 20-epimerization resulted in unique activity profiles. Conformational analysis of the A-ring by H-1 NMR and an X-ray crystallographic analysis of the alpha alpha beta -isomer 2g are also described.
查看更多

同类化合物

(5β)-17,20:20,21-双[亚甲基双(氧基)]孕烷-3-酮 (5α)-2′H-雄甾-2-烯并[3,2-c]吡唑-17-酮 (3β,20S)-4,4,20-三甲基-21-[[[三(异丙基)甲硅烷基]氧基]-孕烷-5-烯-3-醇-d6 (25S)-δ7-大发酸 (20R)-孕烯-4-烯-3,17,20-三醇 (11β,17β)-11-[4-({5-[(4,4,5,5,5-五氟戊基)磺酰基]戊基}氧基)苯基]雌二醇-1,3,5(10)-三烯-3,17-二醇 齐墩果酸衍生物1 黄麻属甙 黄芪皂苷III 黄芪皂苷 II 黄芪甲苷 IV 黄芪甲苷 黄肉楠碱 黄果茄甾醇 黄杨醇碱E 黄姜A 黄夹苷B 黄夹苷 黄夹次甙乙 黄夹次甙乙 黄夹次甙丙 黄体酮环20-(乙烯缩醛) 黄体酮杂质EPL 黄体酮杂质1 黄体酮杂质 黄体酮杂质 黄体酮EP杂质M 黄体酮EP杂质G(RRT≈2.53) 黄体酮EP杂质F 黄体酮6-半琥珀酸酯 黄体酮 17alpha-氢过氧化物 黄体酮 11-半琥珀酸酯 黄体酮 麦角甾醇葡萄糖苷 麦角甾醇氢琥珀酸盐 麦角甾烷-6-酮,2,3-环氧-22,23-二羟基-,(2b,3b,5a,22R,23R,24S)-(9CI) 麦角甾烷-3,6,8,15,16-五唑,28-[[2-O-(2,4-二-O-甲基-b-D-吡喃木糖基)-a-L-呋喃阿拉伯糖基]氧代]-,(3b,5a,6a,15b,16b,24x)-(9CI) 麦角甾烷-26-酸,5,6:24,25-二环氧-14,17,22-三羟基-1-羰基-,d-内酯,(5b,6b,14b,17a,22R,24S,25S)-(9CI) 麦角甾-8-烯-3-醇 麦角甾-8,24(28)-二烯-26-酸,7-羟基-4-甲基-3,11-二羰基-,(4a,5a,7b,25S)- 麦角甾-7,22-二烯-3-酮 麦角甾-7,22-二烯-17-醇-3-酮 麦角甾-5,24-二烯-26-酸,3-(b-D-吡喃葡萄糖氧基)-1,22,27-三羟基-,d-内酯,(1a,3b,22R)- 麦角甾-5,22,25-三烯-3-醇 麦角甾-4,6,8(14),22-四烯-3-酮 麦角甾-1,4-二烯-3-酮,7,24-二(乙酰氧基)-17,22-环氧-16,25-二羟基-,(7a,16b,22R)-(9CI) 麦角固醇 麦冬皂苷D 麦冬皂苷D 麦冬皂苷 B